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Background
Polybrominated diphenyl ethers (PBDEs) 
have been added to a variety of household 
products, including electronics, carpets, and 
the polyurethane foam in furniture, to delay 
combustion and meet fire safety require-
ments (Darnerud et al. 2001). PBDEs are not 
chemically bound to the products to which 
they are added and leach into the environ-
ment over time (Sjödin et al. 2003). Resistant 
to degradation, PBDEs are persistent in the 
environment and have become ubiquitous 
contaminants (Darnerud et al. 2001; Hites 
2004). Dust and diet are thought to be the 
primary sources of exposure to PBDEs in 
the general population (Fraser et al. 2009; 
Johnson et al. 2010; Stapleton et al. 2008, 
2012; Wu et al. 2007); however, infants 
are also exposed to PBDEs prenatally and 
through breastfeeding (Johnson-Restrepo and 
Kannan 2009; Toms et al. 2009).
Toxicological data indicate that PBDEs 
disrupt endocrine function (Butt and 
Stapleton 2013; Ellis-Hutchings et al. 2006; 
Richardson et al. 2008; Stoker et al. 2004; 
Szabo et al. 2009; Zhou et al. 2001, 2002). 
Prenatal and early-life exposures to PBDEs 
have been shown to affect body weight in 
early development in animals (Fernie et al. 
2006; Gee and Moser 2008; Kim et al. 2009; 
Kodavanti et al. 2010; Suvorov et al. 2009). 
The direction of association, however, has not 
been consistent across studies; some report 
increases in body weight following exposure 
to specific congeners (e.g., Suvorov et al. 
2009), and others report no association, or 
decreases in body weight (Kim et al. 2009; 
Kodavanti et al. 2010). Observed differences 
by sex, which have been inconsistent, further 
complicate our understanding of the relation-
ship between PBDEs and early-life growth 
and adiposity (Fernie et al. 2006; Gee and 
Moser 2008; Kim et al. 2009; Kodavanti et al. 
2010; Suvorov et al. 2009). Few studies have 
investigated early-life exposure in human 
populations; however, prenatal PBDE expo-
sures have been inversely associated with 
birth weight and body mass index (BMI) in 
newborn infants in some (Chao et al. 2007; 
Harley et al. 2011; Zhang et al. 2011) but 
not all studies (Mazdai et al. 2003; Tan 
et al. 2009). The implications of exposures 
to PBDEs in infancy on children’s growth 
remain unknown. Thus, we prospectively 
investigated the association between early-life 
exposure to PBDEs through breast milk and 
early childhood weight-for-age, height-for-age, 




The Pregnancy, Infection and Nutrition 
(PIN) Babies Study began in 2004 to follow 
the infants born to women who participated 
in the PIN Pregnancy and Postpartum 
studies through 3 years of age (Daniels et al. 
2010). Women in this study were enrolled 
from the University of North Carolina 
(UNC) prenatal care clinics early in preg-
nancy. Self-administered questionnaires, tele-
phone interviews, and a brief questionnaire 
at the hospital after delivery were used to 
collect health and lifestyle information during 
the pregnancy. Information on postpartum 
health and lifestyle, as well as children’s devel-
opment, was collected during three in-home 
interviews at 3, 12, and 36 months post-
partum. Children’s physicians also provided 
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information on growth and development at 
well-baby doctor visits. All children in the 
PIN Babies study were singleton births and 
free from major birth defects (n = 585). For 
these analyses we have further restricted to 
term infants (> 37 weeks gestation). All study 
protocols were approved by the Institutional 
Review Board at the University of North 
Carolina-Chapel Hill and the Centers for 
Disease Control and Prevention (CDC), and 
all mothers provided informed consent.
Sample Collection
Of the 585 women in the PIN Babies 
Study, 304 mothers were still lactating and 
provided breast milk samples at 3 months 
postpartum. Women providing breast milk 
samples were similar to those not providing 
samples with respect to age, but had higher 
educational attainment (82.2% vs. 71.1% 
had at least college education). Participants 
providing samples were also more likely to 
be white (11.4% or participants with samples 
were nonwhite whereas 27.6% of participants 
without milk samples were nonwhite). Details 
of the breast milk sample collection are avail-
able in the study by Daniels et al. (2010). 
Briefly, lactating women followed written 
instructions to pump both breasts, gently 
mix milk, and use a plastic pipette to transfer 
milk into three 1.5-mL tubes. Women stored 
the milk in their freezer until a research team 
picked up the sample during a home data 
collection visit later the same day. Samples 
were then transported on ice to –80°C storage 
freezers until they were analyzed.
Sample Analysis
Breast milk samples were analyzed for 9 
PBDE congeners by the Organic Analytical 
Toxicology Branch of the National Center 
for Environmental Health at the CDC using 
previously described methods (Sjödin et al. 
2004). Briefly, milk samples were added to 
diatomaceous earth packed in a solid-phase 
extraction cartridge (3 mL) and 13C-labeled 
internal standards were added. Target 
analytes and lipids were extracted using an 
automated modular solid-phase extraction 
system, which dried the sample onto the 
diatomaceous earth with pressurized nitrogen 
and eluted analytes and lipids with dichlo-
romethane. Lipid content was determined 
gravimetrically, and the final analytical 
determination of PBDEs was performed by 
gas chromatography/isotope-dilution high-
resolution mass spectrometry. Both wet-
weight and  lipid- normalized concentrations 
(reported as nanograms per gram of lipid) 
were produced. Two quality controls and two 
blank samples were added to each batch of 
16 study samples. Quality assurance practices 
in the laboratory were regularly monitored 
(Sjödin et al. 2004).
Anthropometric Measurement
Infant length (the usual method used before 
24 months of age) or standing height and 
weight were recorded by health care profes-
sionals during well-baby visits, which are 
recommended by the American Academy of 
Pediatrics at 1, 2, 4, 6, 9, 12, 15, 18, 24, 30, 
and 36 months of age (AAP 2007). Because 
there was some variability in the frequency and 
timing of visits, we linked measurements to 
the child’s age at the time of the visit (reported 
by the health care provider) or, when age was 
not recorded, to age calculated using the visit 
date and the child’s date of birth. If the day 
of the month was not reported for a visit, we 
used the 15th of the month in calculation 
of age. We excluded information for visits 
conducted before breast milk samples were 
collected (≤ 3 months postpartum) to ensure 
that exposure temporally preceded outcomes. 
At the 36-month home visit, PIN Babies study 
staff also conducted in-home assessments of 
weight and standing height, according to the 
National Health and Nutrition Examination 
Surveys protocols (CDC 2007).
Weight and length/height of each child 
were compared to the CDC/National Center 
for Health Statistics (NCHS) growth charts 
to calculate sex-standardized weight-for-age, 
height-for-age, and weight-for-height z-scores 
(WAZ, HAZ, and WHZ, respectively) 
(Kuczmarski et al. 2002). Measurements that 
corresponded to z-scores > 5 or < –5 were 
considered implausible and were excluded 
from analyses (n = 33 observations).
Statistical Analysis
A total of 1,457 WAZ (mean, 5.9; 1–10 per 
child), 1,414 HAZ (mean, 5.7; 1–13 per 
child), and 1,432 WHZ (mean, 5.8; 1–10 
per child) measurements were available for 
the 246 children the PIN cohort from 3 
through 36 months of age. Measurements 
were concentrated in the first year (ages 
3–12 months, n = 843 measurements of 
246 children); however, 350 measurements 
(n = 229 children) were made between 12 
and 24 months, and 277 (n = 192 children) 
measurements were made after children 
were 24 months of age. To determine how 
PBDEs related to WAZ, HAZ, and WHZ in 
early childhood, we used linear mixed-effects 
regression models. Mixed-effects models 
easily accommodate data that are correlated 
(multiple measurements in each child) with 
varying numbers of measurements with 
variable spacing between measurements 
(Fitzmaurice et al. 2004). Because PBDE 
concentrations in breast milk are highly corre-
lated, we used separate models to examine 
the association between quartiles of breast 
milk levels of each of the five most detected 
PBDEs (BDEs 28, 47, 99, 100, and 153) and 
WAZ, HAZ, and WHZ. A summary measure 
of PBDEs is sometimes calculated; however, 
because a number of previous studies have 
shown differences in the biological activity of 
PBDE congeners, we present results for each 
congener separately. We included random 
effects in all models to allow for child-specific 
variation in both size and growth rates. 
Because we anticipated that the relationship 
between age and anthropometric measure-
ments may not be linear, we investigated a 
linear trend in age at the time of the measure-
ment as well as a quadratic trend for the 
fixed and random effects. Using a restricted 
maximum likelihood ratio test, we determined 
including the quadratic term for random 
effects improved model fit.
As reported previously for this popula-
tion, five PBDE congeners—BDEs 28, 47, 
99, 100, and 153—were detected in ≥ 91% 
of samples (Daniels et al. 2010). Milk samples 
with PBDE values below the limit of detec-
tion (LOD) were assigned a concentration 
of the LOD divided by the square root of 
2 for statistical analyses. The four PBDEs 
congeners infrequently detected [in < 70% of 
the PIN Babies sample; BDEs 66, 85, 154, 
183 (Daniels et al. 2010)] were not evalu-
ated in relation to childhood anthropometric 
measurements. Because PBDEs are lipophilic, 
levels in breast milk are often adjusted for lipid 
content in epidemiologic studies. Although 
investigators generally agree that adjustment 
is beneficial, the most appropriate method of 
adjustment remains unclear (O’Brien et al. 
2015; Schisterman et al. 2005). Accordingly, 
we used multiple methods to account for 
confounding by the percent lipid in milk 
samples. First, we conducted analyses using 
lipid normalized PBDE concentrations. We 
also included wet-weight concentrations in 
regression models and included lipid as a 
covariate. Finally, we conducted analyses of 
lipid-normalized concentrations with lipid 
included as a covariate (O’Brien et al. 2015). 
In general the results were similar using all 
methods. Here, we present results using lipid-
normalized concentrations, which are more 
commonly presented, and discuss differences 
observed using other methods of adjustment.
Based on our a priori expectation of their 
association with both PBDE milk concentra-
tions and childhood anthropometric measure-
ments, we adjusted analyses for maternal age 
(≤ 25 years, 26–30 years, 31–35 years, and 
≥ 36 years), race (white vs. nonwhite), smoking 
status during pregnancy (yes vs. no), prepreg-
nancy BMI (< 25, 25–30, and > 30), parity 
(0 vs. ≥ 1), and the child’s age at the time of 
the measurement (continuous age in months 
and age2). We examined the appropriate form 
(continuous or nominal) for each covariate 
in relation to the outcomes (form of variables 
used is reflected in Table 1). We included a 
time-varying covariate for breastfeeding status 
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at the time of each anthropometric measure-
ment, indicating that the child was currently 
breastfeeding, recently breastfed (within 
2 months), or was no longer breastfeeding. We 
did not adjust for maternal education or gesta-
tional weight gain because these factors were 
not strongly related to PBDE levels in breast 
milk and had little impact on the relationships 
between milk exposure and anthropometric 
measurements. Because we anticipated that the 
impact of exposure to PBDEs via lactation may 
vary with age, we also considered an interac-
tion term between quartiles of PBDEs and age. 
Interaction terms between PBDE concentra-
tions and age were not statistically significant 
and did not provide additional insights into 
the relationship between PBDEs and anthro-
pometric measurements. Thus, we present 
results for the average effect of PBDE exposure 
via breast milk from 3 months of age through 
36 months of age.
We hypothesized that the potential 
pathway by which PBDE exposures may be 
associated with growth is through endocrine 
disruption, which suggests the possibility of 
differential associations by sex. We conducted 
sex-stratified analyses to investigate differences 
in associations between boys and girls. All 
analyses were conducted in SAS (version 9.2; 
SAS Institute Inc., Cary, NC).
Results
Of the children whose mothers provided milk 
samples (n = 304), 266 (87.5%) had height or 
weight measurements (children with measure-
ments did not differ from other children with 
respect to included covariates). We excluded 
children who were born < 37 weeks gesta-
tion (n = 20). Our final sample consisted of 
246 children with at least 1 measurement 
of height or weight and a maximum of 13 
measurements (> 1,400 measurements for 
each outcome; median measurements per 
child, 6.0; interquartile range, 4–8 measure-
ments). As in the larger PIN Babies cohort, 
mothers tended to be > 31 years of age at 
the time of their child’s birth (52.6%) and 
were predominantly white (88.6%; Table 1). 
Children in our sample were slightly more 
likely to be male (54.3%) and were generally 
breastfed longer than 10 months (64.2%). 
WAZ and HAZ for children in our sample 
were slightly higher at a given age than the 
2000 CDC normative population (mean 
WAZ, 0.1; mean HAZ, 0.5). However, chil-
dren’s WHZ tended to be lower, indicating 
that PIN Babies participants were slightly 
leaner than the normative population.
As reported previously in the PIN babies 
cohort, BDEs 28, 47, 99, 100, and 153 were 
detected frequently in breast milk samples 
(≥ 90.7% of samples; Table 2) and were gener-
ally correlated with each other (Daniels et al. 
2010). Levels of BDE-47 tended to be higher 
than those of the other congeners (median 
breast milk level, 26.8 ng/g lipid), and the 
levels of BDE-28 were generally the lowest 
(median breast milk level, 2.0 ng/g lipid).
Associations between lipid-normalized 
PBDE levels in breast milk and WAZ, 
HAZ, and WHZ are shown in Figures 1, 
2, and 3, respectively [effect estimates and 
95% confidence intervals (CIs) presented in 
Tables S1–S3]. PBDE exposures via breast milk 
were generally not associated with early-life 
anthropometric measures (WAZ, HAZ, and 
WHZ) in the PIN Babies cohort as a whole, 
Table 1. Selected characteristics of included PIN 
Babies participants.
Characteristic
n (%) or 
Mean ± SD













Less than college graduate 39 (15.9)
College graduate 88 (35.8)
Graduate training or degree 119 (48.4)
Smoking during pregnancy
Yes 9 ( 3.7)
No 232 ( 94.3)







≥ 15 months 45 (18.3)
Maternal prepregnancy BMI (kg/m2) 23.4 ± 4.7
Child WAZa 0.1 ± 1.1
Child HAZb 0.5 ± 1.0
Child WHZc –0.1 ± 1.2
a1,457 observations for 239 participants (measured 
between 1 and 13 times). b1,414 observations for 
240 participants (measured between 1 and 10 times). 
c1,432 observations for 239 participants (measured 
between 1 and 10 times).
Table 2. Lipid-adjusted concentrations (ng/g lipid) of commonly detected PBDEs in 246 breast milk 





Q1 Q2 Q3 Q4
BDE-28 97.1 (0.3) 3.2 ND to 1.3 1.4 to 2.0 2.1 to 3.7 3.8 to 49.6
BDE-47 99.6 (1.3) 50.2 ND to 15.7 15.8 to 27.7 27.8 to 54.2 54.3 to 1,430
BDE-99 90.7 (1.1) 10.4 ND to 2.65 2.8 to 5.2 5.3 to 11.2 11.3 to 299
BDE-100 98.4 (0.3) 10.4 ND to 2.4 2.5 to 5.15 5.25 to 10.4 10.5 to 188
BDE-153 99.2 (0.3) 14.8 ND to 2.65 2.8 to 5.6 5.7 to 13.5 13.55 to 229
ND (nondetectable) values are treated as the LOD divided by the square root of 2 in the calculation of the mean.
Figure 1. Mean difference estimates and 95% CIs by quartile of PBDE congener [1st quartile (referent) = 
circle; 2nd quartile = square; 3rd quartile = triangle; 4th quartile = diamond] for WAZ, adjusted for age (age 
and age2), maternal age (≤ 25 years, 26–30 years, 31–35 years, and ≥ 36 years), race (white vs. nonwhite), 
prepregnancy BMI (< 25, 25–30, and > 30), parity (0 vs. ≥ 1), smoking during pregnancy (yes vs. no), and 
breastfeeding status (current, within the last 2 months, and no longer breastfeeding): (A) full cohort; (B) 
boys only; (C) girls only. 
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after adjustment for age, maternal age, race, 
prepregnancy BMI, parity, smoking during 
pregnancy, and breastfeeding status. Effect 
estimates generally hovered around the null, 
did not follow a consistent pattern across the 
concentration gradient, and were imprecisely 
estimated. Different methods of adjusting 
for the lipid content of milk (e.g., including 
lipid as a covariate) produced slightly different 
results; however, results with these methods 
remained largely null and did not provide 
additional insights regarding the relationship 
between locational exposure to PBDEs and 
 anthropometric measures in early childhood.
When we stratified by sex, higher levels 
of lipid-normalized PBDEs in milk tended 
to be associated with decreased WHZ for 
boys, particularly for BDEs 28, 47, and 100; 
however, as in the full cohort (boys and girls 
combined), the patterns were inconsistent 
across the concentration gradient and impre-
cisely estimated and generally not statisti-
cally significant (Figure 3B). Results for 
WAZ were similar, with high PBDE levels 
in breast milk generally associated with lower 
WAZ in boys, after comparing all quartiles 
of exposure to the lowest quartile; but the 
results were not completely consistent and 
imprecise (Figure 1B). Associations between 
lipid-normalized PBDE levels and anthro-
pometric measurements were largely null for 
girls except for BDE-153, which our data 
suggest may be inversely associated with 
WAZ and WHZ [Figures 1C and 2C; mean 
difference (95% CI) = –0.47 (–0.96, 0.03) 
and –0.24 (–0.69, 0.22) comparing the 4th 
quartile to the 1st, respectively]. When we 
adjusted for lipids by adding a term for lipid 
to the regression model, effect estimates were 
further attenuated, with two notable excep-
tions: First, the inverse association between 
the highest quartile of BDE-153 and WHZ 
among girls was unchanged [mean differences 
comparing the 4th quartile to the 1st, 0.46 
(95% CI: –0.98, 0.07)]. Second, the associa-
tion between BDE-28 and WHZ among girls 
was more prominently positive [mean differ-
ence 2nd quartile, 0.69 (95% CI: 0.19, 1.22); 
mean difference 3rd quartile, 0.21 (95% CI: 
–0.32, 0.75); mean difference 4th quartile, 0.68 
(95% CI: 0.06, 1.31)].
Discussion
Despite widespread exposure to PBDEs, 
relatively little is known about their poten-
tial to affect health, particularly regarding 
children’s growth. In our cohort of central 
North Carolina children, higher PBDE levels 
in breast milk were generally not associated 
with anthropometric measurements from 3 
through 36 months of age. There was some 
suggestion of decreased WHZ in boys more 
highly exposed via breast milk and increased 
WHZ in girls; however our small sample 
hindered our ability to more precisely 
assess differences in the associations by 
sex. Although not a direct measurement of 
adiposity, WHZ is more reflective of fat mass 
than WAZ or HAZ.
Several previous toxicological studies have 
documented the endocrine-disrupting proper-
ties of PBDEs and reported sex differences in 
offspring weight gain in the early postnatal 
period, although the direction of reported 
associations has been inconsistent. For 
example, prenatal exposure to the commercial 
pentaPBDE mixture, DE-71, was associated 
with decreased weight gain in female but 
not male rat pups (Kodavanti et al. 2010). 
Conversely, prenatal exposure to BDE-209 
was related to lower weight gain in early devel-
opment in male rat pups but not female rat 
Figure 2. Mean difference estimates and 95% CIs by quartile of PBDE congener [1st quartile (referent) = 
circle; 2nd quartile = square; 3rd quartile = triangle; 4th quartile = diamond] for HAZ, adjusted for age (age 
and age2), maternal age (≤ 25 years, 26–30 years, 31–35 years, and ≥ 36 years), race (white vs. nonwhite), 
prepregnancy BMI (< 25, 25–30, and > 30), parity (0 vs. ≥ 1), smoking during pregnancy (yes vs. no), and 
breastfeeding status (current, within the last 2 months, and no longer breastfeeding): (A) full cohort; (B) 
boys only; (C) girls only.
Figure 3. Mean difference estimates and 95% CIs by quartile of PBDE congener [1st quartile (referent) = 
circle; 2nd quartile = square; 3rd quartile = triangle; 4th quartile = diamond] for WHZ, adjusted for age (age 
and age2), maternal age (≤ 25 years, 26–30 years, 31–35 years, and ≥ 36 years), race (white vs. nonwhite), 
prepregnancy BMI (< 25, 25–30, and ≥ 30), parity (0 vs. ≥ 1), smoking during pregnancy (yes vs. no), and 
breastfeeding status (current, within the last 2 months, and no longer breastfeeding): (A) full cohort; (B) 
boys only; (C) girls only.
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pups (Kim et al. 2009)—a finding consistent 
with our results in boys, which suggested 
lower WHZ with increasing PBDE levels in 
breast milk.
The only other study to assess postnatal 
exposure to PBDE found an inverse associa-
tion between serum BDE-153 levels and BMI 
percentile at 7 years of age (Erkin-Cakmak 
et al. 2015), a finding consistent with our 
results suggesting lactational exposure 
to BDE-153 may be associated with lower 
WHZ. Additionally, previous studies have 
reported prenatal exposures to be associated 
with lower birth weight and BMI in newborn 
infants (Chao et al. 2007; Harley et al. 2011; 
Zhang et al. 2011). Our data for BDE-153 
and WHZ are consistent with these results; 
however, we did not consistently observe 
similar associations for other congeners. There 
are several possible explanations for differ-
ences in the results of our work and those 
from previous research. A primary differ-
ence is that our results are based on post-
natal PBDE exposure through breast milk, 
which is correlated with but different from 
the prenatal exposure metrics used by most 
previous studies. We did not have exposure 
data to explore associations reflecting the 
prenatal period, which may be a more sensi-
tive developmental stage for PBDEs exposure. 
It is possible that the associations between 
PBDEs and children’s height and weight 
differs over time. We did not see differences 
by age when including an interaction term in 
models; however, the children in our study 
were relatively young, and most of the anthro-
pometric measurements were collected in the 
first year of life, potentially limiting our ability 
to detect differences through 3 years of age 
(results not shown).
PBDE milk concentrations in our cohort 
were higher than concentrations reported by 
most similarly timed studies from the United 
States and considerable higher than those 
reported abroad (Daniels et al. 2010; Erdoğrul 
et al. 2004; Frederiksen et al. 2009; Johnson-
Restrepo et al. 2007; Schecter et al. 2003; She 
et al. 2007; Toms et al. 2007). Although a 
clear trend has yet to be established, exposure 
to PBDEs is likely to decrease in the coming 
decades because their use has been phased out 
in many countries.
Our work should be interpreted in the 
context of several limitations. PBDEs are 
ubiquitous contaminants in the home envi-
ronment (e.g., Stapleton et al. 2009), raising 
the possibility that breast milk samples, which 
were collected by mothers in their own homes, 
may been contaminated. Although mothers 
were given instruction on sample collection 
to reduce this possibility, exposure misclas-
sification is possible and may have biased 
results toward the null. Similarly, we have 
not accounted for competing environmental 
exposures or dietary patterns in these analyses. 
However, by design, all children included in 
analyses were breastfed through 3 months of 
age, and most were breastfed > 10 months. 
Although we had > 1,400 anthropometric 
measurements, our samples size of 246 
children was relatively small, limiting our 
ability to investigate difference in effect by sex 
or over time. Additionally, generalizability of 
our results is limited by the homogeneity of 
the PIN Babies cohort. PIN Babies included 
mothers that attended UNC prenatal care 
clinics, delivered generally healthy singleton 
infants, completed several years of follow-up, 
and were not very demographically diverse. 
Mothers in the PIN Babies cohort were highly 
educated. These mothers may have been more 
likely to intervene to mitigate suboptimal 
growth, potentially masking any impact of 
early-life PBDE exposures. Finally, most of 
the height and weight measurements for the 
PIN Babies cohort were collected at doctors’ 
offices. These measurements may be subject 
to random error because they were collected at 
multiple medical office sites by staff members 
who had not been trained using a standard 
method. Such error would likely diminish our 
ability to detect associations. However, we 
found excellent correlation between the health 
providers’ measurements and our standardized 
study measurements; among 50 participants 
with both measures collected within a 2-week 
period around 36 months of age, the correla-
tion between the two measurements was 0.85 
(p < 0.001 for correlation). This comparison 
offers assurance that health provider measure-
ments provide reliable measures of growth 
between study visits and contribute favorably 
to our analysis. Additionally, we benefitted 
from ability to evaluate this association in a 
well-characterized, somewhat homogenous, 
group of mothers and children with reasonable 
exposure variability.
Conclusions
We observed little evidence of associations 
between early-life PBDE exposures via breast 
milk and anthropometric measurements; 
however, our results suggesting possible 
differences in effects between boys and girls 
prompt the need for sex-specific investiga-
tions in larger cohorts. Further study is needed 
to determine whether PBDEs are adversely 
associated with children’s growth and whether 
that trend persists throughout as children age, 
particularly because altered growth in early life 
has long-term health implications.
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